Expert Opinion on Drug Safety, Volume 21, Issue 6 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 21, Issue 6 (2022)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Volume 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Safety associated with rapid acting antidepressants

Foreword

Editorial
Rapid-acting antidepressants in psychiatry: psychedelics, episodic treatments, innovation, and clarion call for methodologic rigor in drug development
Roger S. McIntyre
Pages: 715-716
Published online: 15 Jul 2022
CitationforRapid-acting antidepressants in psychiatry: psychedelics, episodic treatments, innovation, and clarion call for methodologic rigor in drug development | Full Text | References | PDF (113.6 KB) | EPUB
  • 1234 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Can ketamine be a safe option for treatment-resistant bipolar depression?
Balwinder Singh, Jennifer L. Vande Voort, Mark A. Frye & Simon Kung
Pages: 717-720
Published online: 28 Feb 2022
First Page PreviewforCan ketamine be a safe option for treatment-resistant bipolar depression? | Full Text | References | PDF (201.2 KB) | EPUB
  • 6878 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?
M. Ishrat Husain, Madeha Umer & Benoit H. Mulsant
Pages: 721-724
Published online: 11 Apr 2022
First Page PreviewforCan the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits? | Full Text | References | PDF (149.3 KB) | EPUB
  • 2409 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability
Michael D. Kritzer, Chi-Un Pae & Prakash S. Masand
Pages: 725-732
Published online: 29 Apr 2022
AbstractforKey considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability | Full Text | References | PDF (333.4 KB) | EPUB
  • 534 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment
Marcus A. Doyle, Susan Ling, Leanna M.W. Lui, Paul Fragnelli, Kayla M. Teopiz, Roger Ho, Joshua D. Di Vincenzo, Joshua D. Rosenblat, Emily S. Gillissie, Danica Nogo, Felicia Ceban, Muhammad Youshay Jawad & Roger S. McIntyre
Pages: 733-743
Published online: 03 May 2022
AbstractforHallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 802 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression
Amanda Tamman, Amit Anand & Sanjay J. Mathew
Pages: 745-759
Published online: 14 Mar 2022
AbstractforA comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression | Full Text | References | PDF (444.3 KB) | EPUB
  • 723 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
Giordano Novak Rossi, Jaime E. C. Hallak, José Carlos Bouso Saiz & Rafael G. Dos Santos
Pages: 761-776
Published online: 27 Apr 2022
AbstractforSafety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges | Full Text | References | PDF (1.5 MB) | EPUB
  • 1282 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Long-term safety of ketamine and esketamine in treatment of depression
Sina Nikayin, Eva Murphy, John H. Krystal & Samuel T. Wilkinson
Pages: 777-787
Published online: 19 Apr 2022
AbstractforLong-term safety of ketamine and esketamine in treatment of depression | Full Text | References | PDF (371.1 KB) | EPUB
  • 1867 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Giordano Novak Rossi, Isabella Caroline da Silva Dias, Glen Baker, José Carlos Bouso Saiz, Serdar M. Dursun, Jaime E. C. Hallak & Rafael G. Dos Santos
Pages: 789-801
Published online: 23 Mar 2022
AbstractforAyahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability | Full Text | References | PDF (1 MB) | EPUB
  • 366 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Craving and addictive potential of esketamine as side effects?
Laura Orsolini, Virginio Salvi & Umberto Volpe
Pages: 803-812
Published online: 04 May 2022
AbstractforCraving and addictive potential of esketamine as side effects? | Full Text | References | PDF (420.8 KB) | EPUB
  • 392 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
A review of potential neuropathological changes associated with ketamine
Danica Nogo, Hana Nazal, Yuetong Song, Kayla M. Teopiz, Roger Ho, Roger S. McIntyre, Leanna M.W. Lui & Joshua D. Rosenblat
Pages: 813-831
Published online: 08 May 2022
AbstractforA review of potential neuropathological changes associated with ketamine | Full Text | References | PDF (1.4 MB) | EPUB
  • 546 Views
  • 2 CrossRef citations
  • 0Altmetric

Systematic Review

Article
The therapeutic potential of psilocybin: a systematic review
Jan van Amsterdam & Wim van den Brink
Pages: 833-840
Published online: 02 Mar 2022
AbstractforThe therapeutic potential of psilocybin: a systematic review | Full Text | References | PDF (316.4 KB) | EPUB
  • 2328 Views
  • 6 CrossRef citations
  • 0Altmetric

Systematic Review and Meta-analysis

The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis
Muhammad Youshay Jawad, Joshua D. Di Vincenzo, Felicia Ceban, Saja Jaberi, Leanna M.W. Lui, Emily S. Gillissie, Yazen Alnafeesi, Joshua D. Rosenblat & Roger S. McIntyre
Pages: 841-852
Published online: 06 Apr 2022
AbstractforThe efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 907 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A. Zarate & Gustavo H. Vazquez
Pages: 853-866
Published online: 09 Mar 2022
AbstractforEfficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 1340 Views
  • 8 CrossRef citations
  • 0Altmetric

Explore articles